Celldex Therapeutics reported $-82.25M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
AbbVie USD 6.88B 156M Sep/2026
Agenus USD 15.05M 656K Mar/2026
Amgen USD 4.68B 65M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Celldex Therapeutics USD -82.25M 1.63M Sep/2026
Glaxosmithkline GBP 2.13B 166M Sep/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Northwest Biotherapeutics USD -10.9M 3.42M Mar/2026
Pfizer USD 662M 5M Sep/2026
Rigel Pharmaceuticals USD 14.06M 13.61M Sep/2024
Roche Holding CHF 11.46B 1.91B Jun/2026